Key result
Rosuvastatin and chitosan preserve glomerular morphology in hyperlipidemic models, boosting volumetric density by up to ~142%.
Why the study?
Does rosuvastatin or chitosan improve renal structure and lipid metabolism in rabbits fed a high-fat diet?
RCT (n=28)
randomly divided
Does rosuvastatin or chitosan improve renal structure and lipid metabolism in rabbits fed a high-fat diet?
In a rabbit model, both rosuvastatin and chitosan improved lipid profiles and ameliorated kidney morphological changes induced by a high-fat diet.
Background and Objectives: This study compared the effects of rosuvastatin and chitosan on the kidneys of rabbits fed a high-fat diet. Materials and Methods: In total, 28 New Zealand White rabbits (Oryctolagus cuniculus) were randomly divided into four groups of 7 rabbits: a control group (CG) fed a regular diet; a hyperlipidic group (HG) fed the regular diet and 20 mL of egg yolk daily; and the third (RG) and fourth (ChiG) groups fed the HG diet plus rosuvastatin and chitosan, respectively. Cholesterol, triglyceride, glucose, creatinine, and urea levels were analyzed. After kidney excision, glomerular height and length were analyzed and stereological analysis was conducted. The Kruskal–Wallis and Dunn multiple comparison tests were used for statistical analysis, and a p value of <0.05 was considered significant. Results: The chicken egg yolk diet was successful in inducing a hypercholesterolemic state. Total cholesterol levels showed a significant reduction in rabbits treated with rosuvastatin, and chitosan and rosuvastatin significantly reduced triglyceride, VLDL, creatinine, and glucose levels. The size of the glomerulus was increased significantly in the HG rabbits. Stereological analysis showed a mean glomerular volumetric density of 8.27 ± 3.27, 4.14 ± 2.87, 10.03 ± 3.22, and 6.18 ± 3.50 vV% for CG, HG, RG, and ChiG, respectively. Conclusions: Chitosan reduced triglyceride, VLDL, creatinine, and glucose levels but was less effective than rosuvastatin. Kidney morphology was slightly altered in the animals fed a high-fat diet, and these changes were ameliorated by treatment with chitosan or rosuvastatin.
No takes yet. Share an insight, caveat, or question.
Chagas et al. (2026) conducted an RCT in Hypercholesterolemia (n=28). Rosuvastatin and chitosan vs. Hyperlipidic diet (regular diet + egg yolk) and regular diet was evaluated on Mean glomerular volumetric density. In rabbits fed a high-fat diet, rosuvastatin and chitosan ameliorated kidney morphology changes, with mean glomerular volumetric densities of 10.03 and 6.18 vV% vs 4.14 vV% in controls.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: